These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20935019)

  • 1. Improving CKD-MBD management in haemodialysis patients: barrier analysis for implementing better practice.
    Toussaint ND; Pedagogos E; Beavis J; Becker GJ; Polkinghorne KR; Kerr PG
    Nephrol Dial Transplant; 2011 Apr; 26(4):1319-26. PubMed ID: 20935019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to mineral and bone disorder clinical practice guidelines in chronic kidney disease.
    Panawong W; Chaiyakum A; Pongskul C
    J Med Assoc Thai; 2011 Oct; 94(10):1175-83. PubMed ID: 22145501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of a multidisciplinary kidney disease clinic in achieving treatment guideline targets.
    Thanamayooran S; Rose C; Hirsch DJ
    Nephrol Dial Transplant; 2005 Nov; 20(11):2385-93. PubMed ID: 16046506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of care assessment and adherence to the international guidelines considering dialysis, water treatment, and protection against transmission of infections in university hospital-based dialysis units in Cairo, Egypt.
    Ibrahim S
    Hemodial Int; 2010 Jan; 14(1):61-7. PubMed ID: 19758297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic kidney disease (CKD) and bone. CKD-MBD managements and view in the future].
    Watanabe M; Suzuki H; Akizawa T
    Clin Calcium; 2009 Apr; 19(4):559-65. PubMed ID: 19329836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). KDIGO CKD-MBD Clinical Practice Guideline].
    Tsukamoto Y
    Clin Calcium; 2010 Jul; 20(7):1021-7. PubMed ID: 20585180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study).
    Razavian M; Heeley EL; Perkovic V; Zoungas S; Weekes A; Patel AA; Anderson CS; Chalmers JP; Cass A
    Nephrol Dial Transplant; 2012 Apr; 27(4):1396-402. PubMed ID: 22053091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of attitude of physicians on updates in the management of anemia in chronic kidney disease patients.
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):410-6. PubMed ID: 19414943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units.
    Arenas MD; Alvarez-Ude F; Gil MT; Soriano A; Egea JJ; Millán I; Amoedo ML; Muray S; Carretón MA
    Nephrol Dial Transplant; 2006 Jun; 21(6):1663-8. PubMed ID: 16464885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Executing change in the management of chronic kidney disease: perspectives on guidelines and practice.
    Levin A; Stevens LA
    Med Clin North Am; 2005 May; 89(3):701-9. PubMed ID: 15755474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitude of physicians in Saudi Arabia towards anemia treatment strategies in patients with chronic kidney disease.
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):65-72. PubMed ID: 17237894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study.
    Brandenburg VM; Schlieper G; Heussen N; Holzmann S; Busch B; Evenepoel P; Vanholder R; Meijers B; Meert N; Fassbender WJ; Floege J; Jahnen-Dechent W; Ketteler M
    Nephrol Dial Transplant; 2010 Aug; 25(8):2672-9. PubMed ID: 20172849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to physician adherence to a subfertility guideline.
    Haagen EC; Nelen WL; Hermens RP; Braat DD; Grol RP; Kremer JA
    Hum Reprod; 2005 Dec; 20(12):3301-6. PubMed ID: 16055463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?
    Martin KJ; González EA
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):440-6. PubMed ID: 21292848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study.
    Gallieni M; De Luca N; Santoro D; Meneghel G; Formica M; Grandaliano G; Pizzarelli F; Cossu M; Segoloni G; Quintaliani G; Di Giulio S; Pisani A; Malaguti M; Marseglia C; Oldrizzi L; Pacilio M; Conte G; Dal Canton A; Minutolo R
    J Nephrol; 2016 Feb; 29(1):71-8. PubMed ID: 25986389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical practice guidelines: barriers to durability after effective early implementation.
    Brand C; Landgren F; Hutchinson A; Jones C; Macgregor L; Campbell D
    Intern Med J; 2005 Mar; 35(3):162-9. PubMed ID: 15737136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
    Craver L; Marco MP; Martínez I; Rue M; Borràs M; Martín ML; Sarró F; Valdivielso JM; Fernández E
    Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K/DOQI guidelines for bone metabolism and disease in chronic kidney disease patients: some therapeutic implications.
    Uribarri J;
    Semin Dial; 2004; 17(5):349-50. PubMed ID: 15461740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.